help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mor, O.
Right arrow Articles by Reichert, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mor, O.
Right arrow Articles by Reichert, N.

Am. J. Respir. Cell Mol. Biol., Vol 16, No. 1, 01 1997, 9-13.

Absence of p53 mutations in malignant mesotheliomas

O Mor, P Yaron, M Huszar, A Yellin, O Jakobovitz, F Brok-Simoni, G Rechavi and N Reichert
Molecular Biology Laboratory, Chaim Sheba Medical Center, Ramat Gan, Israel.

Mutations in the p53 gene are the most common genetic alterations found in human malignancies. In this study, a search was done for mutations in the conserved regions of the p53 gene in malignant mesotheliomas. Thirteen malignant mesotheliomas collected over the preceding 12 yr and maintained in paraffin blocks were examined by polymerase chain reaction (PCR) followed by both single-strand conformation polymorphism (SSCP) and denaturing gradient-gel electrophoresis (DGGE). Direct sequence analysis was performed in cases suspected for mutations. No mutations in exons 5 to 8 of the p53 gene were detected. Our results suggest that malignant transformation of human mesothelioma cells does not require inactivation of p53 by point mutations in the conserved regions of the gene.


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
R. Lazzarini, S. Moretti, S. Orecchia, P.-G. Betta, A. Procopio, and A. Catalano
Enhanced Antitumor Therapy by Inhibition of p21waf1 in Human Malignant Mesothelioma
Clin. Cancer Res., August 15, 2008; 14(16): 5099 - 5107.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
M. A. Jackson, I. Lea, A. Rashid, S. D. Peddada, and J. K. Dunnick
Genetic Alterations in Cancer Knowledge System: Analysis of Gene Mutations in Mouse and Human Liver and Lung Tumors
Toxicol. Sci., April 1, 2006; 90(2): 400 - 418.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. J. Gordon, G. N. Rockwell, R. V. Jensen, J. G. Rheinwald, J. N. Glickman, J. P. Aronson, B. J. Pottorf, M. D. Nitz, W. G. Richards, D. J. Sugarbaker, et al.
Identification of Novel Candidate Oncogenes and Tumor Suppressors in Malignant Pleural Mesothelioma Using Large-Scale Transcriptional Profiling
Am. J. Pathol., June 1, 2005; 166(6): 1827 - 1840.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Aldieri, S. Orecchia, D. Ghigo, L. Bergandi, C. Riganti, B. Fubini, P. G. Betta, and A. Bosia
Simian Virus 40 Infection Down-Regulates the Expression of Nitric Oxide Synthase in Human Mesothelial Cells
Cancer Res., June 15, 2004; 64(12): 4082 - 4084.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A Baldi, D Santini, F Vasaturo, M Santini, G Vicidomini, M P. Di Marino, V Esposito, A M Groeger, G Liuzzi, B Vincenzi, et al.
Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma
Thorax, May 1, 2004; 59(5): 428 - 433.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Vivo, W. Liu, and V. C. Broaddus
c-Jun N-terminal Kinase Contributes to Apoptotic Synergy Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand plus DNA Damage in Chemoresistant, p53 Inactive Mesothelioma Cells
J. Biol. Chem., July 3, 2003; 278(28): 25461 - 25467.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. Xia, Z. Xu, X. Yuan, K. Uematsu, L. You, K. Li, L. Li, F. McCormick, and D. M. Jablons
Induction of Apoptosis in Mesothelioma Cells by Antisurvivin Oligonucleotides
Mol. Cancer Ther., July 1, 2002; 1(9): 687 - 694.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
G. J. Gordon, K. Appasani, J. P. Parcells, N. K. Mukhopadhyay, M. T. Jaklitsch, W. G. Richards, D. J. Sugarbaker, and R. Bueno
Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma
Carcinogenesis, June 1, 2002; 23(6): 1017 - 1024.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A Baldi, A M Groeger, V Esposito, R Cassandro, G Tonini, T Battista, M P Di Marino, B Vincenzi, M Santini, A Angelini, et al.
Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival
Thorax, April 1, 2002; 57(4): 353 - 356.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
X. X. Cao, I. Mohuiddin, F. Ece, D. J. McConkey, and W. R. Smythe
Histone Deacetylase Inhibitor Downregulation of bcl-xl Gene Expression Leads to Apoptotic Cell Death in Mesothelioma
Am. J. Respir. Cell Mol. Biol., November 1, 2001; 25(5): 562 - 568.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C.-T. Yang, L. You, K. Uematsu, C.-C. Yeh, F. McCormick, and D. M. Jablons
p14ARF Modulates the Cytolytic Effect of ONYX-015 in Mesothelioma Cells with Wild-type p53
Cancer Res., August 1, 2001; 61(16): 5959 - 5963.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
W. Liu, E. Bodle, J. Y. Chen, M. Gao, G. D. Rosen, and V. C. Broaddus
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Chemotherapy Cooperate to Induce Apoptosis in Mesothelioma Cell Lines
Am. J. Respir. Cell Mol. Biol., July 1, 2001; 25(1): 111 - 118.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. Pataer, W. R. Smythe, R. Yu, B. Fang, T. McDonnell, J. A. Roth, and S. G. Swisher
Adenovirus-mediated Bak gene transfer induces apoptosis in mesothelioma cell lines
J. Thorac. Cardiovasc. Surg., January 1, 2001; 121(1): 0061 - 67.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
Y. Pilatte, C. Vivo, A. Renier, L. Kheuang, A. Greffard, and M.-C. Jaurand
Absence of SV40 Large T-Antigen Expression in Human Mesothelioma Cell Lines
Am. J. Respir. Cell Mol. Biol., December 1, 2000; 23(6): 788 - 793.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
C.-T. Yang, L. You, C.-C. Yeh, J. W.-C. Chang, F. Zhang, F. McCormick, and D. M. Jablons
Adenovirus-Mediated p14ARF Gene Transfer in Human Mesothelioma Cells
J Natl Cancer Inst, April 19, 2000; 92(8): 636 - 641.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. Waheed, Z. S. Guo, G. A. Chen, T. S. Weiser, D. M. Nguyen, and D. S. Schrump
Antisense to SV40 Early Gene Region Induces Growth Arrest and Apoptosis in T-Antigen-positive Human Pleural Mesothelioma Cells
Cancer Res., December 1, 1999; 59(24): 6068 - 6073.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
L. Xu, B. J. Flynn, S. Ungar, H. I. Pass, K. Linnainmaa, K. Mattson, and B. I. Gerwin
Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen
Carcinogenesis, May 1, 1999; 20(5): 773 - 783.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. R. Narasimhan, L. Yang, B. I. Gerwin, and V. C. Broaddus
Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax
Am J Physiol Lung Cell Mol Physiol, July 1, 1998; 275(1): L165 - L171.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
V. Courtney Broaddus
Asbestos, the Mesothelial Cell and Malignancy: A Matter of Life or Death
Am. J. Respir. Cell Mol. Biol., December 1, 1997; 17(6): 657 - 659.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 1997 American Thoracic Society.